FTRE

Congress Trades

Name	Value	Action	Amount Range	Price	Current Price
James French HillRepublican $8.0k SellJun 23, 2025 $1k-$15k -- --

Insider Trades

Name	Value	Action	Price	Current Price
Parks RobertChief Accounting Officer $27k2k shares SellMay 18, 2026 $13.44 --
Mcconnell Jill G.Chief Financial Officer $17k1.8k shares SellMar 16, 2026 $9.22 --
Morais Mark A.Chief Operating Officer $17k1.8k shares SellMar 16, 2026 $9.22 --
Mcconnell Jill G.Chief Financial Officer $23k2.5k shares SellMar 10, 2026 $9.21 --
Mcconnell Jill G.Chief Financial Officer $23k2.5k shares SellMar 10, 2026 $8.93 --
Morais Mark A.Chief Operating Officer $21k2.3k shares SellMar 10, 2026 $9.21 --

News

globenewswire.comFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 10

globenewswire.comFortrea to Attend Jefferies Global Healthcare Conferenceglobenewswire.comJun 2

seekingalpha.comFortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 5

zacks.comFortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimateszacks.comMay 5

Trade FTRE

About Fortrea Holdings Inc.

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.

CEO: Anshul Thakral
IPO Date: Jun 20, 2023

Market Data

Open: $15.76
High: $16.05
Low: $14.88
Volume: 2.5M
Avg Volume: 1.3M
52W High: $18.67
52W Low: $4.36

Valuation

Market Cap: $1.4B
Enterprise Value: $2.4B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $88M
Revenue: $2.7B
Net Income: $-986M
Cash: $175M
Debt: $1.1B

Events

EarningsAug 5

EPS est. 0.18